BRS3(FM3) - Inflammation Resolution Capacity
(Inflammation Resolution & Lipid Mediator Balance)
Primary Mechanisms
1. Mission & Overview
Mission
Enable active termination of inflammation through pro-resolving lipid signals rather than relying on simple immune suppression.
Overview
A functional control point governing active termination of inflammation through pro-resolving lipid mediators (specialised molecules that switch inflammation off) rather than simple suppression of immune activity.
- Modulates cytokine signalling tone across IL-6, TNF-α, and CRP-linked pathways.
- Balances arachidonic-acid inflammatory mediators against EPA/DHA-derived pro-resolving mediators.
- Depends on essential fatty acid balance and antioxidant substrate sufficiency.
2. Primary Biological Effects
↑ resolvins/protectins/maresins; ↑ debris clearance; ↓ unresolved inflammation
4. Mechanistic Basis (Integrated FM Narrative)
4.1 Functional Rationale
Inflammatory messenger regulation and production of specialised resolving mediators contribute to an appropriate inflammatory response and its resolution. Resolution is a distinct biological task from suppressing inflammation.
4.2 Evidence Summary
Human endotoxin-challenge evidence reads cytokine responses; pathway evidence identifies EPA- and DHA-derived specialised pro-resolving mediators and substrate competition. These sources establish different parts of inflammatory signalling and resolution rather than a single dietary resolution experiment. [1, 2, 6, 8]
If messenger regulation and resolving-mediator production operate appropriately, they would support progression from inflammatory response toward resolution. Substrate availability and cytokine changes alone do not establish clinical resolution or define an intake that optimises it.
4.3 Suboptimal Function & Its Effects
Inflammation resolution capacity may weaken when habitual EPA/DHA intake and omega-3/omega-6 dietary balance become chronically unfavourable for specialized pro-resolving mediator formation.
Low omega-3 intake may limit EPA/DHA substrate availability for resolvin, protectin, and maresin pathways. Excessive omega-6 dominance, low oily-fish consumption, poor dietary fatty-acid diversity, and chronic inflammatory load may further constrain specialised pro-resolving mediator formation [Serhan & Petasis, 2011].
Oxidative damage to membrane lipids—when BRS3-FM2-PM5 — Lipid Peroxidation Control is strained—may further compromise the lipid environment required for active resolution rather than prolonged cytokine elevation.
These pressures may impair BRS3-FM3-PM7 — Cytokine Network Modulation and weaken BRS3-FM3-PM8 — Eicosanoid / SPM Balance. At the FM level, this may shift BRS3(FM3) toward impaired inflammation resolution capacity.
5. Connected Mechanisms
- BRS1-FM3-PM7 — Neuronal Membrane DHA Incorporation — membrane long-chain PUFA substrate pools feeding specialized pro-resolving mediator formation
- BRS3-FM1-PM1 - NF-kB Signalling Regulation — nF-kB Signalling Regulation
- BRS3-FM1-PM2 - Gut-Derived Inflammatory Signalling — gut-Derived Inflammatory Signalling
- BRS3-FM2-PM5 - Lipid Peroxidation Control — lipid Peroxidation Control
- BRS5-FM1-PM2 — LPS / Endotoxin Containment — gut endotoxin containment upstream of systemic cytokine network tone
- BRS5(FM1) — Gut Barrier Integrity and Immune Interface — gut–immune interface context influencing inflammatory resolution substrate availability
- BRS6(FM1) — Glycaemic–Insulin Stability & Cognitive Energy Availability — post-prandial glycaemic context conditioning inflammatory cytokine expression
7. Phenome Connections
These outcomes describe translational contexts for the FM as an integrated biological capacity. They are not single-mechanism treatment claims. FM confidence uplift: FM confidence may exceed that of any individual child PM only where multiple PMs converge on the same phenome and the integrated FM biology provides additional biological rationale (biological uplift) beyond the individual mechanisms.
Each Phenome relationship has two independent ratings. They are not combined or averaged.
Biology → Phenome Relationship Strength
How direct and important is this biological mechanism expected to be to the Phenome within the BRAIN model?
Evidence Confidence
How strongly does the adjudicated evidence support this particular biology → Phenome relationship?
- Biology → Phenome Relationship Strength: Medium
- Evidence Confidence: Medium
- Synthesis: Resolution-oriented lipid mediator and cytokine-network balance contribute to the inflammatory environment associated with apprehensive worry and perseverative thought. Human intervention evidence (Kiecolt-Glaser et al., 2011) demonstrates that omega-3 supplementation reduced inflammatory cytokine production alongside anxiety symptoms in stressed adults, providing translational support for this Biology → Phenome relationship.
- Key References:
- Biology → Phenome Relationship Strength: Low
- Evidence Confidence: Low
- Synthesis: Inflammation-resolution capacity intersects mitochondrial and reward-processing dysfunction in depression translational models; omega-3 resolution biology provides mechanistic context without direct anhedonia-outcome claims on this FM.
- Key References:
8. References
- [1] Serhan and Petasis (2011) — Resolvins and Protectins in Inflammation Resolution
- [2] Ferguson et al. (2014) — Omega‐3 PUFA Supplementation and the Response to Evoked Endotoxemia in Healthy Volunteers
- [3] Kiecolt-Glaser et al. (2011) — A Randomized Controlled Trial
- [4] Song et al. (2023) — A Fatal Blow in Depression
- [5] Gruber et al. (2023) — Impact of Insulin and Insulin Resistance on Brain Dopamine Signalling and Reward
- [6] Slavich & Irwin (2014) — A Social Signal Transduction Theory of Depression
- [7] Marsland et al. (2017) — Systemic Inflammation and Resting State Connectivity of the Default Mode Network
- [8] Simopoulos (2011) — Omega-6/Omega-3 Ratio and the Brain